Pictures

Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Gettysburg's 150th

Re-enactors and visitors mark the 150th anniversary of the Battle of Gettysburg, often described as the turning point of the Civil War.  Slideshow 

Photo

Gay pride parades

Revelers celebrate in gay pride parades around the world, on the heels of twin victories on same-sex marriage in the U.S. Supreme Court.  Slideshow 

Sponsored Links

Teva says cleared of wrongdoing after man's death in France

Related Topics

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. REUTERS/Ronen Zvulun

A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011.

Credit: Reuters/Ronen Zvulun

JERUSALEM | Mon Jul 1, 2013 4:30am EDT

JERUSALEM (Reuters) - Israel's Teva Pharmaceutical Industries said on Monday that French prosecutors had cleared it of any operational failures after the death of a 92-year-old man last month.

A preliminary investigation showed there was no trace of the sedative zopiclone in the drugmaker's diuretic furosemide, Teva said in a statement.

French police said on June 9 they were treating the man's death as "suspicious" after he was given medicine that may have been wrongly labeled as a diuretic drug.

France's pharmaceutical watchdog ANSM had asked pharmacies to take 190,000 boxes of Teva's drug off their shelves just two days before the man died, saying they may contain zopiclone.

"The results of the investigation clear Teva of all suspicion of failure in its operations," Teva Chief Executive Jeremy Levin said.

Teva, the world's No.1 generic drugmaker, said ANSM's decision to recall the drugs had been the right one, even though it proved unnecessary in retrospect.

(Reporting by Ari Rabinovitch; Editing by Louise Ireland)
Health
 
We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (0)
Be the first to comment on reuters.com.
Add yours using the box above.